Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $603.30M.
ENTERPRISE VALUE (EV)
$603.30M
SOPHiA GENETICS S.A.
Market Cap
$625.86M
Enterprise Value (EV)
$603.30M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| SOPHiA GENETICS S.A. (SOPH) | $625.86M | $603.30M |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $629.87M | $486.05M |
| Climb Bio, Inc. (CLYM)vs › | $618.02M | $575.22M |
| OmniAb, Inc. (OABI)vs › | $635.70M | $630.28M |
| Aura Biosciences, Inc. (AURA)vs › | $636.13M | $584.89M |
| Prime Medicine, Inc. (PRME)vs › | $640.29M | $705.32M |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $601.63M | $919.37M |
| Starling Oncology, Inc. (STLN)vs › | $656.34M | $719.72M |
| AngioDynamics, Inc. (ANGO)vs › | $594.45M | $540.59M |
| MiMedx Group, Inc. (MDXG)vs › | $662.92M | $528.58M |
Market Cap
$625.86M
Total Debt
$47.73M
Cash
$70.29M
Enterprise Value
$603.30M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
